Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: A randomized trial

JAMA

Volumn 310, Issue 15, 2013, Pages 1571-1580

  Harris, Anthony D ^a   Pineles, Lisa ^a   Belton, Beverly ^b   Johnson, J Kristie ^a   Shardell, Michelle ^a   Loeb, Mark ^c   Newhouse, Robin ^d   Dembry, Louise ^b   Braun, Barbara ^e   Perencevich, Eli N ^f   Hall, Kendall K ^g   Morgan, Daniel J ^a,h   Shahryar, Syed K ⁱ   Price, Connie S ^j   Gadbaw, Joseph J ^k   Drees, Marci ^l   Kett, Daniel H ^m   Muñoz Price, L Silvia ⁿ   Jacob, Jesse T ^o   Herwaldt, Loreen A ^p   Sulis, Carol A ^q   Yokoe, Deborah S ^r   Maragakis, Lisa ^s   Lissauer, Matthew E ^t   Zervos, Marcus J ^u   Warren, David K ^v   Carver, Robin L ^w   Anderson, Deverick J ^x   Calfee, David P ^y   Bowling, Jason E ^z   Safdar, Nasia ^aa   more..

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b YALE NEW HAVEN HEALTH SYSTEM   (United States)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF MARYLAND SCHOOL OF NURSING   (United States)

^e Joint Commission   (United States)

^f UNIVERSITY OF IOWA HEALTH CARE   (United States)

^g AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁱ St Luke's Medical Center Phoenix   (United States)

^j DENVER HEALTH MEDICAL CENTER   (United States)

^k Lawrence and Memorial Hospital   (United States)

^l CHRISTIANA HOSPITAL   (United States)

^m UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

ⁿ JACKSON MEMORIAL HOSPITAL   (United States)

^o EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^p UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^q BOSTON MEDICAL CENTER   (United States)

^r BRIGHAM AND WOMEN S HOSPITAL   (United States)

^s JOHNS HOPKINS HOSPITAL   (United States)

^t UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^u HENRY FORD HOSPITAL   (United States)

^v BARNES JEWISH HOSPITAL   (United States)

^w WAKEMED HEALTH AND HOSPITALS   (United States)

^x DUKE UNIVERSITY   (United States)

^y WEILL CORNELL MEDICAL COLLEGE   (United States)

^z University Hospital   (United States)

^aa University of Wisconsin Health   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERSE OUTCOME; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; HAND WASHING; HUMAN; INFECTION CONTROL; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTECTIVE CLOTHING; SURGICAL GLOVE; SURGICAL GOWN; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 84885640932     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.277815     Document Type: Article

References (41)

1. Talbot GH, Bradley J, Edwards JE Jr, Gilbert D, Scheld M, Bartlett JG; Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis. 2006;42(5):657-668. doi:10.1086/499819.
2. Klevens RM, Edwards JR, Richards CL Jr, et al. Estimating health care-associated infections and deaths in US hospitals, 2002. Public Health Rep. 2007;122(2):160-166.
3. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: ameta-analysis. Clin Infect Dis. 2003;36(1):53-59. doi:10.1086/345476.
4. DiazGranados CA, Jernigan JA. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection. J Infect Dis. 2005;191(4):588-595. doi:10.1086/427512.
5. Morgan DJ, Rogawski E, Thom KA, et al. Transfer of multidrug-resistant bacteria to healthcare workers' gloves and gowns after patient contact increases with environmental contamination. Crit Care Med. 2012;40(4):1045-1051. doi:10.1097/CCM.0b013e31823bc7c8.
6. Hayden MK, Blom DW, Lyle EA, Moore CG, Weinstein RA. Risk of hand or glove contamination after contact with patients colonized with vancomycin-resistant Enterococcus or the colonized patients' environment. Infect Control Hosp Epidemiol. 2008;29(2):149-154. doi:10.1086/524331.
7. Boyce JM, Pittet D; Healthcare Infection Control Practices Advisory Committee: HICPAC/SHEA/ APIC/IDSA Hand Hygiene Task Force. Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR Recomm Rep. 2002;51(RR-16):1-45.
8. Siegel JD, Rhinehart E, Jackson M, Chiarello L; Health Care Infection Control Practices Advisory Committee. 2007 guideline for isolation precautions: Preventing transmission of infectious agents in health care settings. Am J Infect Control. 2007;35(10)(suppl 2):S65-S164. doi:10.1016/j.ajic.2007.10.007.
9. Wright MO, Hebden JN, Harris AD, et al. Aggressive control measures for resistant Acinetobacter baumannii and the impact on acquisition ofmethicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in a medical intensive care unit. Infect Control Hosp Epidemiol. 2004;25(2):167-168. doi:10.1086/502370.
10. Klein BS, Perloff WH, Maki DG. Reduction of nosocomial infection during pediatric intensive care by protective isolation. N Engl J Med. 1989;320(26):1714-1721.
11. Safdar N, Marx J, Meyer NA, Maki DG. Effectiveness of preemptive barrier precautions in controlling nosocomial colonization and infection by methicillin-resistant Staphylococcus aureus in a burn unit. Am J Infect Control. 2006;34(8): 476-483. doi:10.1016/j.ajic.2006.01.011.
12. Yin J, Schweizer ML, Herwaldt LA, Pottinger JM, Perencevich EN. Benefits of universal gloving on hospital-acquired infections in acute care pediatric units. Pediatrics. 2013;131(5):e1515-20. doi:10.1542/peds.2012-3389.
13. Morgan DJ, Pineles LL, Shardell M, et al. The effect of contact precautions on healthcare worker activity in acute care hospitals. Infect Control Hosp Epidemiol. 2013;34(1):69-73.
14. Morgan DJ, Diekema DJ, Sepkowitz K, Perencevich EN. Adverse outcomes associated with Contact Precautions: a review of the literature. Am J Infect Control. 2009;37(2):85-93. doi:10.1016/j.ajic.2008.04.257.
15. Stelfox HT, Bates DW, Redelmeier DA. Safety of patients isolated for infection control. JAMA. 2003;290(14):1899-1905. doi:10.1001/jama.290.14.1899.
16. Donner A, Klar N. Design and Analysis of Cluster Randomization Trials in Health Research. London, England: Arnold Publishing; 2000.
17. Campbell MK, Piaggio G, Elbourne DR, Altman DG; CONSORT Group. Consort 2010 statement: extension to cluster randomised trials. BMJ. 2012;345:e5661. doi:10.1136/bmj.e5661.
18. Huskins WC, Huckabee CM, O'Grady NP, et al; STAR*ICU Trial Investigators. Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med. 2011;364(15):1407-1418. doi:10.1056/NEJMoa1000373.
19. Climo MW, Yokoe DS, Warren DK, et al. Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med. 2013;368(6):533-542. doi:10.1056/NEJMoa1113849.
20. Morgan DJ, Meddings J, Saint S, et al SHEA Research Network. Does nonpayment for hospital-acquired catheter-associated urinary tract infections lead to overtesting and increased antimicrobial prescribing? Clin Infect Dis. 2012;55(7):923-929. doi:10.1093/cid/cis556.
21. Siegel JD, Rhinehart E, Jackson M, Chiarello L; Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;35(10)(suppl 2):S165-S193. doi:10.1016/j.ajic.2007.10.006.
22. Griffin F, Resar R. IHI Global Trigger Tool for Measuring Adverse Events. Second ed. Institute for Healthcare Improvement Innovation Series White Paper; 2009. http://www.ihi.org/knowledge/pages/IHIWhitePapers/ IHIGlobalTriggerToolWhitePaper.aspx. Updated August 13, 2013; Accessed September 12, 2013.
23. Wright M, Hebden JN, Allen-Bridson K, Morrell GC, Horan T. Health care-associated infections studies project: case 4. Am J Infect Control. 2011;39(1):64-65. doi:10.1016/j.ajic.2010.12.001.
24. Wright MO, Hebden JN, Allen-Bridson K, Morrell GC, Horan T. Health care-associated infections studies project: case 3. Am J Infect Control. 2010;38(8):642-643. doi:10.1016/j.ajic.2010.07.001.
25. Wright MO, Hebden JN, Allen-Bridson K, Morrell GC, Horan T. Healthcare-associated infections studies project: an American Journal of Infection Control and National Healthcare Safety Network data quality collaboration. Am J Infect Control. 2010;38(5):416-418.
26. Wright MO, Hebden JN, Allen-Bridson K, Morrell GC, Horan T. Health care-associated infections studies project: case 2. Am J Infect Control. 2010;38(7):557-558. doi:10.1016/j.ajic.2010.06.003.
27. Robinson GL, Harris AD, Morgan DJ, Pineles L, Belton BM, Johnson JK; Benefits of Universal Gloving and Gowning (BUGG) Study Group. Survival of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus spp for an extended period of transport. J Clin Microbiol. 2012;50(7):2466-2468. doi:10.1128/JCM.00911-12.
28. Richter SS, Heilmann KP, Dohrn CL, et al. Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009. Antimicrob Agents Chemother. 2011;55(9):4154-4160. doi:10.1128/AAC.00315-11.
29. Bell JM, Paton JC, Turnidge J. Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates. J Clin Microbiol. 1998;36(8):2187-2190.
30. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309-332. doi:10.1016/j.ajic.2008.03.002.
31. Landrigan CP, Parry GJ, Bones CB, Hackbarth AD, Goldmann DA, Sharek PJ. Temporal trends in rates of patient harm resulting from medical care. N Engl J Med. 2010;363(22):2124-2134. doi:10.1056/NEJMsa1004404.
32. Institute for Healthcare Improvement. How-to guide: Improving hand hygiene. http: //www.ihi.org/knowledge/Pages/Tools/ HowtoGuideImprovingHandHygiene.aspx. Updated July 8, 2011. Accessed September 12, 2013.
33. Thompson SG, Pyke SD, Hardy RJ. The design and analysis of paired cluster randomized trials: an application ofmeta-analysis techniques. Stat Med. 1997;16(18):2063-2079.
34. Brookmeyer R, Chen YQ. Person-time analysis of paired community intervention trials when the number of communities is small. Stat Med. 1998;17(18):2121-2132.
35. Ho J, Tambyah PA, Paterson DL. Multiresistant gram-negative infections: a global perspective. Curr Opin Infect Dis. 2010;23(6):546-553. doi:10.1097/QCO.0b013e32833f0d3e.
36. Yokoe DS, Mermel LA, Anderson DJ, et al. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29(S1)(suppl 1):S12-S21.
37. Harris AD, Furuno JP, Roghmann MC, et al. Targeted surveillance of methicillin-resistant Staphylococcus aureus and its potential use to guide empiric antibiotic therapy. Antimicrob Agents Chemother. 2010;54(8):3143-3148. doi:10.1128/AAC.01590-09.
38. Huang SS, Septimus E, Kleinman K, et al CDC Prevention Epicenters Program; AHRQ DECIDE Network and Healthcare-Associated Infections Program. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med. 2013;368(24):2255-2265. doi:10.1056/NEJMoa1207290.
39. McGann P, Kwak YI, Summers A, Cummings JF, Waterman PE, Lesho EP. Detection of qacA/B in clinical isolates of methicillin-resistant Staphylococcus aureus from a regional healthcare network in the eastern United States. Infect Control Hosp Epidemiol. 2011;32(11):1116-1119. doi:10.1086/662380.
40. Lee AS, Macedo-Vinas M, François P, et al. Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococcus aureus carriage after decolonization therapy: a case-control study. Clin Infect Dis. 2011;52(12):1422-1430. doi:10.1093/cid/cir233.
41. Feng PJ, Kallen AJ, Ellingson K, Muder R, Jain R, Jernigan JA. Clinical incidence of methicillinresistant Staphylococcus aureus (MRSA) colonization or infection as a proxy measure for MRSA transmission in acute care hospitals. Infect Control Hosp Epidemiol. 2011;32(1):20-25. doi:10.1086/657668.